Sanjay Gandhi to Antineoplastic Agents, Hormonal
This is a "connection" page, showing publications Sanjay Gandhi has written about Antineoplastic Agents, Hormonal.
Connection Strength
0.140
-
Locker GY, Mansel R, Cella D, Dobrez D, Sorensen S, Gandhi SK. Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen Alone or in Combination) trial. Breast Cancer Res Treat. 2007 Dec; 106(2):229-38.
Score: 0.074
-
Unger HA, Kane RD, Fox KM, Gandhi S, Alzola C, Lamerato L, Newling D, Kumar S. Relative importance of PSA in prostate cancer treatment. Urol Oncol. 2005 Jul-Aug; 23(4):238-45.
Score: 0.066